Jayagen Biologics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 18-05-2024
- Paid Up Capital ₹ 0.10 M
as on 18-05-2024
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2021)
- Net Worth -2738.44%
(FY 2021)
- Total Assets 35.94%
(FY 2021)
About Jayagen Biologics
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Krishnaraj Mannangatti and Chandrasekaran Sathyavani serve as directors at the Company.
- CIN/LLPIN
U24302TN2019PTC132487
- Company No.
132487
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Nov 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media
Who are the key members and board of directors at Jayagen Biologics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishnaraj Mannangatti  | Director | 08-Nov-2019 | Current |
| Chandrasekaran Sathyavani | Director | 08-Nov-2019 | Current |
Financial Performance of Jayagen Biologics.
Jayagen Biologics Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 2738.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Jayagen Biologics?
Unlock access to Jayagen Biologics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Cybrids Agro Biotech Private LimitedActive 5 years 1 monthKrishnaraj Mannangatti and Chandrasekaran Sathyavani are mutual person
Chetti Masala Food And Spices Private LimitedActive 6 years 2 monthsKrishnaraj Mannangatti and Chandrasekaran Sathyavani are mutual person
- Abtri Biotech Private LimitedActive 8 years 5 months
Krishnaraj Mannangatti and Chandrasekaran Sathyavani are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jayagen Biologics?
Unlock and access historical data on people associated with Jayagen Biologics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jayagen Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jayagen Biologics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
